Biocon Biologics
Sohel Dalal is a Senior Scientific Manager at Biocon Biologics, with previous experience at Novozymes South Asia Pvt. Ltd., Cadila Pharmaceuticals, and Yahsraj Biotechnology Pvt Ltd. SOHEL holds a Ph.D. in Biochemistry from the Indian Institute of Technology, Delhi, and has a strong background in downstream process development of various biologics and vaccines. Their expertise lies in purification and characterization of enzymes and antigens, making him a valuable asset in the biotechnology and pharmaceutical industries.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics